Boxer Capital as of June 30, 2022
Portfolio Holdings for Boxer Capital
Boxer Capital holds 76 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Mirati Therapeutics | 8.5 | $134M | 2.0M | 67.13 | |
| Cytokinetics Com New (CYTK) | 5.2 | $83M | 2.1M | 39.29 | |
| BeiGene Sponsored Adr (ONC) | 5.1 | $81M | 500k | 161.85 | |
| Revolution Medicines (RVMD) | 4.3 | $68M | 3.5M | 19.49 | |
| Apellis Pharmaceuticals (APLS) | 3.7 | $59M | 1.3M | 45.22 | |
| Springworks Therapeutics (SWTX) | 3.2 | $51M | 2.1M | 24.62 | |
| Pmv Pharmaceuticals (PMVP) | 3.2 | $50M | 3.5M | 14.25 | |
| Prometheus Biosciences | 3.1 | $48M | 1.7M | 28.23 | |
| Tyra Biosciences (TYRA) | 2.9 | $46M | 6.4M | 7.15 | |
| Relay Therapeutics (RLAY) | 2.8 | $45M | 2.7M | 16.75 | |
| Iteos Therapeutics | 2.8 | $44M | 2.2M | 20.60 | |
| Merus N V (MRUS) | 2.7 | $43M | 1.9M | 22.64 | |
| Turning Point Therapeutics I | 2.7 | $43M | 571k | 75.25 | |
| Amylyx Pharmaceuticals (AMLX) | 2.7 | $42M | 2.2M | 19.26 | |
| Reata Pharmaceuticals Cl A | 2.4 | $38M | 1.2M | 30.39 | |
| Spdr Ser Tr S&p Biotech (XBI) | 2.4 | $37M | 500k | 74.27 | |
| Arcus Biosciences Incorporated (RCUS) | 2.3 | $36M | 1.4M | 25.34 | |
| Sage Therapeutics (SAGE) | 2.2 | $35M | 1.1M | 32.30 | |
| Tango Therapeutics (TNGX) | 2.0 | $31M | 6.9M | 4.53 | |
| Ideaya Biosciences (IDYA) | 1.9 | $30M | 2.2M | 13.80 | |
| Bellus Health Com New | 1.9 | $30M | 3.2M | 9.24 | |
| Anaptysbio Inc Common (ANAB) | 1.7 | $26M | 1.3M | 20.30 | |
| Blueprint Medicines (BPMC) | 1.6 | $26M | 507k | 50.51 | |
| Amicus Therapeutics (FOLD) | 1.6 | $25M | 2.3M | 10.74 | |
| Kinnate Biopharma | 1.5 | $23M | 1.8M | 12.61 | |
| Iovance Biotherapeutics (IOVA) | 1.4 | $21M | 1.9M | 11.04 | |
| Day One Biopharmaceuticals I (DAWN) | 1.3 | $21M | 1.2M | 17.90 | |
| Gossamer Bio (GOSS) | 1.3 | $21M | 2.5M | 8.37 | |
| Rocket Pharmaceuticals (RCKT) | 1.3 | $20M | 1.5M | 13.76 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $18M | 600k | 30.42 | |
| ACADIA Pharmaceuticals (ACAD) | 1.1 | $18M | 1.3M | 14.09 | |
| Point Biopharma Global | 1.1 | $17M | 2.5M | 6.81 | |
| Nuvalent Inc-a (NUVL) | 1.0 | $16M | 1.2M | 13.56 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $16M | 1.1M | 14.53 | |
| Nurix Therapeutics (NRIX) | 1.0 | $16M | 1.2M | 12.67 | |
| Sarepta Therapeutics (SRPT) | 0.9 | $15M | 200k | 74.96 | |
| Biomea Fusion (BMEA) | 0.9 | $14M | 1.2M | 11.98 | |
| Nuvation Bio Com Cl A (NUVB) | 0.9 | $14M | 4.3M | 3.24 | |
| Cullinan Oncology (CGEM) | 0.9 | $14M | 1.1M | 12.82 | |
| Milestone Pharmaceuticals (MIST) | 0.9 | $14M | 2.2M | 6.15 | |
| Fate Therapeutics (FATE) | 0.8 | $12M | 500k | 24.78 | |
| GH Research Ordinary Shares (GHRS) | 0.6 | $10M | 1.0M | 9.98 | |
| Prothena Corp SHS (PRTA) | 0.5 | $8.1M | 300k | 27.15 | |
| Akero Therapeutics (AKRO) | 0.5 | $7.9M | 832k | 9.45 | |
| Rain Therapeutics | 0.4 | $6.5M | 1.2M | 5.56 | |
| Ascendis Pharma A/S Sponsored Adr (ASND) | 0.4 | $6.5M | 70k | 92.96 | |
| Ngm Biopharmaceuticals | 0.4 | $6.4M | 500k | 12.82 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.4 | $6.1M | 1.3M | 4.87 | |
| 2Seventy Bio Common Stock | 0.4 | $6.1M | 460k | 13.20 | |
| DBV Technologies S A Sponsored Adr | 0.3 | $5.4M | 2.1M | 2.55 | |
| Black Diamond Therapeutics (BDTX) | 0.3 | $5.0M | 2.0M | 2.46 | |
| BCLS Acquisition Corp Com Cl A | 0.3 | $5.0M | 500k | 9.90 | |
| Theseus Pharmaceuticals | 0.3 | $4.9M | 892k | 5.53 | |
| Panacea Acquisition Corp II Cl A Shs | 0.3 | $4.9M | 500k | 9.76 | |
| Oric Pharmaceuticals (ORIC) | 0.3 | $4.7M | 1.1M | 4.48 | |
| Eqrx | 0.3 | $4.7M | 1.0M | 4.69 | |
| 89bio (ETNB) | 0.3 | $4.5M | 1.4M | 3.22 | |
| Selecta Biosciences | 0.3 | $4.3M | 3.3M | 1.31 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.3 | $4.0M | 400k | 9.96 | |
| Atreca Cl A Com (BCEL) | 0.2 | $3.9M | 2.2M | 1.79 | |
| Cogent Biosciences (COGT) | 0.2 | $3.8M | 425k | 9.02 | |
| Solid Biosciences | 0.2 | $3.3M | 5.3M | 0.62 | |
| Mereo Biopharma Group Ads (MREO) | 0.2 | $2.5M | 2.3M | 1.12 | |
| Codiak Biosciences | 0.2 | $2.4M | 850k | 2.88 | |
| Essa Pharma Com New (EPIX) | 0.1 | $2.3M | 725k | 3.15 | |
| Gemini Therapeutics | 0.1 | $2.2M | 1.3M | 1.69 | |
| Omega Alpha SPAC Cl A | 0.1 | $2.0M | 200k | 9.85 | |
| Bioatla (BCAB) | 0.1 | $2.0M | 686k | 2.85 | |
| Aligos Therapeutics | 0.1 | $1.8M | 1.5M | 1.21 | |
| MEI Pharma Com New | 0.1 | $1.8M | 2.9M | 0.60 | |
| Elevation Oncology (ELEV) | 0.1 | $1.2M | 873k | 1.40 | |
| Protara Therapeutics Com Stk (TARA) | 0.0 | $613k | 209k | 2.93 | |
| Cabaletta Bio (CABA) | 0.0 | $572k | 540k | 1.06 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $75k | 267k | 0.28 | |
| Bellicum Pharmaceuticals Com New | 0.0 | $68k | 57k | 1.19 | |
| Surrozen W Exp 08/01/203 (SRZNW) | 0.0 | $13k | 67k | 0.20 |